ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia

被引:108
作者
Chapman, J
Wang, NS
Treves, TA
Korczyn, AD
Bornstein, NM
机构
[1] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Tel Aviv Med Ctr, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel
关键词
angiotensin-converting enzymes; apolipoprotein E; dementia; factor V Leiden; methylenetetrahydrofolate reductase;
D O I
10.1161/01.STR.29.7.1401
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose-There is a growing interest in the use of genetic markers in the differential diagnosis of dementia, In the current study we examined the usefulness of genetic risk factors for vascular disease as markers for vascular dementia (VD), Methods-The groups included 41 patients with VD, 49 patients with dementia of the Alzheimer's type, and 40 age-matched control subjects without dementia. These patients were genotyped for vascular disease-associated polymorphisms in the genes coding for methylenetetrahydrofolate reductase (MTHFR), angiotensin-converting enzyme (ACE), factor V Leiden (FVL), and a common genetic risk factor for AD, apolipoprotein E epsilon 4 (APOE epsilon 4). Results-There was no significant association between ACE, MTHFR, and FVL genotypes with VD whether compared with subjects with AD or with control subjects. There was a higher frequency of APOE epsilon 4 alleles in patients with AD (30%, P=0.016) and VD (26%, P=0.07) compared with control subjects (15%), Conclusions-VD is not associated with the genetic risk factors for vascular disease examined in this study, indicating that the pathogenesis of VD may differ from other vascular diseases.
引用
收藏
页码:1401 / 1404
页数:4
相关论文
共 39 条
[1]  
Amar K, 1996, BMJ-BRIT MED J, V312, P227
[2]  
Arai H, 1997, GERONTOLOGY, V43, P2
[3]   MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C [J].
BERTINA, RM ;
KOELEMAN, BPC ;
KOSTER, T ;
ROSENDAAL, FR ;
DIRVEN, RJ ;
DERONDE, H ;
VANDERVELDEN, PA ;
REITSMA, PH .
NATURE, 1994, 369 (6475) :64-67
[4]   HETEROZYGOSITY FOR HOMOCYSTINURIA IN PREMATURE PERIPHERAL AND CEREBRAL OCCLUSIVE ARTERIAL-DISEASE [J].
BOERS, GHJ ;
SMALS, AGH ;
TRIJBELS, FJM ;
FOWLER, B ;
BAKKEREN, JAJM ;
SCHOONDERWALDT, HC ;
KLEIJER, WJ ;
KLOPPENBORG, PWC .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) :709-715
[5]  
Cacabelos R, 1996, METHOD FIND EXP CLIN, V18, P693
[6]   DELETION POLYMORPHISM IN THE GENE FOR ANGIOTENSIN-CONVERTING ENZYME IS A POTENT RISK FACTOR FOR MYOCARDIAL-INFARCTION [J].
CAMBIEN, F ;
POIRIER, O ;
LECERF, L ;
EVANS, A ;
CAMBOU, JP ;
ARVEILER, D ;
LUC, G ;
BARD, JM ;
BARA, L ;
RICARD, S ;
TIRET, L ;
AMOUYEL, P ;
ALHENCGELAS, F ;
SOUBRIER, F .
NATURE, 1992, 359 (6396) :641-644
[7]   Angiotensin-converting enzyme insertion deletion polymorphism and cerebrovascular disease [J].
Catto, A ;
Carter, AM ;
Barrett, JH ;
Stickland, M ;
Bamford, J ;
Davies, JA ;
Grant, PJ .
STROKE, 1996, 27 (03) :435-440
[8]  
Catto A, 1996, STROKE, V27, P573
[9]   A simple and efficient method for apolipoprotein E genotype determination [J].
Chapman, J ;
Estupinan, J ;
Asherov, A ;
Goldfarb, LG .
NEUROLOGY, 1996, 46 (05) :1484-1485
[10]  
ENGBERSEN AMT, 1995, AM J HUM GENET, V56, P142